Cargando…
European Psychiatric Association guidance on treatment of cognitive impairment in schizophrenia
BACKGROUND: Although cognitive impairment is a core symptom of schizophrenia related to poorer outcomes in different functional domains, it still remains a major therapeutic challenge. To date, no comprehensive treatment guidelines for cognitive impairment in schizophrenia are implemented. METHODS:...
Autores principales: | Vita, Antonio, Gaebel, Wolfgang, Mucci, Armida, Sachs, Gabriele, Barlati, Stefano, Giordano, Giulia Maria, Nibbio, Gabriele, Nordentoft, Merete, Wykes, Til, Galderisi, Silvana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532218/ https://www.ncbi.nlm.nih.gov/pubmed/36059103 http://dx.doi.org/10.1192/j.eurpsy.2022.2315 |
Ejemplares similares
-
European Psychiatric Association guidance on assessment of cognitive impairment in schizophrenia
por: Vita, Antonio, et al.
Publicado: (2022) -
EPA guidance on treatment of negative symptoms in schizophrenia
por: Galderisi, S., et al.
Publicado: (2021) -
EPA guidance on assessment of negative symptoms in schizophrenia
por: Galderisi, S., et al.
Publicado: (2021) -
EPA guidance on the quality of mental health services: A systematic meta-review and update of recommendations focusing on care coordination
por: Gaebel, W., et al.
Publicado: (2020) -
Transitions in mental health care: The European Psychiatric Association contribution to reform in Bulgaria
por: Beezhold, Julian, et al.
Publicado: (2020)